Company file Nº 967 / 1611 · Series B · United States · updated 20 Oct 2026
Curebase
GTM score
57.3
In its stage
301st of 325 Series B
Ranked against 1611 companies indexed as at 20 Oct 2026. The index grows every month, so a rank can move without a company changing.
What they do
AI-powered eClinical platform for ePRO/eCOA, eConsent, EDC, and patient recruitment and engagement in clinical trials
The pillar map
exit criteria metexit criteria partly metexit criteria not metno public signal found
The real colors on all 16 pillars, with each pillar's score, free with an email address.
Our read
We read every map the same way: where the engine is strong, where it's stuck, and what matters most next. Our read on Curebase: our read, unlocks with email
What the full report adds
GTM score over time
Think we got Curebase wrong? and we will take another look. How we score →